Leisure-Time Physical Activity and Reduced Plasma Levels of Obesity-Related Inflammatory Markers (Q56988344)

5

Eric B. Rimm

0 references

Nader Rifai

4

Nader Rifai

0 references

Susan E. Hankinson

2

Susan E. Hankinson

0 references

Gökhan Hotamışlıgil

3

Preventing non-insulin-dependent diabetes

Gökhan S. Hotamisligil

0 references

publication date

September 2003

0 references

published in

Obesity

0 references

volume

11

0 references

issue

9

0 references

page(s)

1055-1064

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Physical activity in the prevention of cardiovascular disease: an epidemiological perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

The role of TNFalpha and TNF receptors in obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Plasma concentrations of soluble TNF-alpha receptors in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Physical activity and hemostatic and inflammatory variables in elderly men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

C-reactive protein and coronary heart disease in western Turkey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Association between physical activity and markers of inflammation in a healthy elderly population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Prospective study of alcohol consumption and risk of coronary disease in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Plasma leptin concentrations and four-year weight gain among US men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Compendium of physical activities: classification of energy costs of human physical activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Validity of self-reported waist and hip circumferences in men and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

The assessment of alcohol consumption by a simple self-administered questionnaire.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Reproducibility and validity of a semiquantitative food frequency questionnaire

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Reproducibility and validity of a self-administered physical activity questionnaire

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Flexible regression models with cubic splines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Strenuous exercise, plasma fibrinogen, and factor VII activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Percent body fat and lean mass explain the gender difference in leptin: analysis and interpretation of leptin in Hispanic and non-Hispanic white adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Function of C-reactive protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Weight loss reduces C-reactive protein levels in obese postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

The potential biological and clinical significance of the soluble tumor necrosis factor receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Plasma cytokine parameters and mortality in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145

Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.145